By using CRISPR and transposon constructs, pigs have been genetically modified to inactivate endogenous retroviruses and to enhance the compatibility of their organs with the human immune and coagulation systems.
This is a preview of subscription content, log in via an institution to check access.
References
Yue, Y. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-020-00613-9 (2020).
White, D. J. G., Langford, G., Cozzi, E. & Young, V. K. Xenotransplantation 2, 213–217 (1995).
Lai, L. et al. Science 295, 1089–1092 (2002).
Dai, Y. et al. Nat. Biotechnol. 20, 251–255 (2002).
Yang, Y. G. & Sykes, M. Nat. Rev. Immunol. 7, 519–531 (2007).
Fischer, K., Kind, A. & Schnieke, A. Xenotransplantation 25, e12431 (2018).
Rieblinger, B. et al. Xenotransplantation 25, e12382 (2018).
Fischer, K. et al. Xenotransplantation 27, e12560 (2020).
Yamamoto, T. et al. Xenotransplantation 27, e12596 (2020).
Niu, D. et al. Science 357, 1303–1307 (2017).
Fiebig, U. et al. Xenotransplantation 25, e12445 (2018).
Niebert, M., Scheef, G. & Tönjes, R. Transplantationsmedizin: Organ der Deutschen Transplantationsgesellschaft 14, 166–170 (2002).
Längin, M. et al. Nature 564, 430–433 (2018).
Ekser, B., Kumar, G., Veroux, M. & Cooper, D. K. C. Curr. Opin. Organ Transplant. 16, 222–230 (2011).
Cooper, D. K. et al. Transplantation 100, 2301–2308 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Fischer, K., Schnieke, A. Extensively edited pigs. Nat Biomed Eng 5, 128–129 (2021). https://doi.org/10.1038/s41551-021-00684-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-021-00684-2
- Springer Nature Limited